What’s New
- 17 July 2020Conditional Approval of Registration of Remdesivir
- 6 July 2020Coronavirus (COVID-19) Update: FDA Issued Emergency Use Authorization for Point of Care Antigen Test
- 4 June 2020FDA Approves Antibiotic to Treat Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia
- 27 February 2020Potential Risks Associated With The Use of Ozone and Ultraviolet (UV) Light Products for Cleaning CPAP Machines and Accessories: FDA Safety Communication
- 31 December 2019Alert on the cluster of pneumonia cases in Wuhan of Mainland
- 19 December 2019First FDA-approved vaccine for the prevention of Ebola virus disease, marking a critical milestone in public health preparedness and response
- 18 September 2019Reporting of Burkholderia cepacia complex. Centre for Health Protection, Letter to Doctor
- 23 August 2019Spain Issues International Warning over Listeriosis Outbreak
- 14 August 2019FDA Approves Breakthrough Drug to Treat Extensively Drug-Resistant Tuberculosis
- 17 July 2019Ebola outbreak in the Democratic Republic of the Congo declared a Public Health Emergency of International Concern
- 12 July 2019Reporting of Candida auris, Centre for Health Protection. Letter to Hospital
- 13 June 2019Important Safety Alert Regarding Use of Fecal Microbiota for Transplantation and Risk of Serious Adverse Reactions Due to Transmission of Multi-Drug Resistant Organisms
- 3 June 2019Tuberculosis and Mycobacterial Infections: An Educational Update Singapore 26 – 28 September 2019
- 1 May 2019First FDA-approved vaccine for the prevention of dengue disease in endemic regions
- 24 April 2019World Immunization Week
- 15 April 2019Measles cases rose nearly four-fold in first quarter 2019: WHO
- 25 March 2019Update on the Situation of Measles and the Recommended Schedule of Measles-containing Vaccine in Childhood Immunisation Programm
- 4 March 2019Scientific recommendations on pertussis vaccination for pregnant women in Hong Kong
- 14 December 2018Educational video on Control of MDROs in Hong Kong
- 16 November 2018Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics